ISRCTN15751828进行中（未招募）1 期
Phase I trial - 2021-006930-37 [The full scientific title will be published within 30 months after the end of the trial]
Omeros Corporation (United States)0 个研究点目标入组 12 人开始时间: 2022年7月15日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended
排除标准
- •The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended
研究者
相似试验
进行中（未招募）
1 期
Phase I trial, CRO code: 21-013The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended.ISRCTN10271810Beckley Psytech Ltd.48
进行中（未招募）
1 期
Phase 1 trial, HMR code: 21-004The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended.Not SpecifiedISRCTN12926361Gedeon Richter Plc104
已完成
Unknown
Phase 1 trial: CA38951Healthy volunteersISRCTN46343886Millicent Pharma Limited36
进行中（未招募）
1 期
Phase I trial: QSC206159Healthy volunteersISRCTN51392723Oxilio Limited12
已完成
1 期
Phase I clinical trial to evaluate the safety,tolerance and immune response ofChikungunya vaccine in healthy adults of 18 to 50 years ageCTRI/2020/04/024533Bharat Biotech International limited20